VivoSim Labs, Inc. Tax Withholding Paid on Stock Awards
VivoSim Labs, Inc. (VIVS) reported Tax Withholding Paid on Stock Awards of $0 for the 12-month period ending 2023-03-31, per its 10-K filed 2023-07-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2023-07-14
- VivoSim Labs, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-03-31 was $0.00.
- VivoSim Labs, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2021-12-31 was $1.00K, a 0.00% change year-over-year.
- VivoSim Labs, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- VivoSim Labs, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $46.00K, a 1050.00% increase from fiscal 2021.
- VivoSim Labs, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2021 was $4.00K, a 93.44% decline from fiscal 2020.
- VivoSim Labs, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2020 was $61.00K, a 72.65% decline from fiscal 2019.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2023-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | $0.00 derived: sum of 2 quarters · filed 2023-07-14 | $0.00 10-K · filed 2023-07-14 | |
| 2022-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | $0.00 10-Q · filed 2023-02-09 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | |||
| 2022-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | $1.00K derived: sum of 2 quarters · filed 2023-07-14 | $46.00K derived: sum of 3 quarters · filed 2023-07-14 | $46.00K 10-K · filed 2023-07-14 |
| 2021-12-31 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | $46.00K derived: sum of 2 quarters · filed 2023-02-09 | $46.00K 10-Q · filed 2023-02-09 | $47.00K derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-10 | $45.00K 10-Q · filed 2022-11-10 | $46.00K derived: sum of 3 quarters · filed 2022-11-10 | $47.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-06 | $1.00K derived: sum of 2 quarters · filed 2022-06-10 | $2.00K derived: sum of 3 quarters · filed 2022-06-10 | $3.00K derived: sum of 4 quarters · filed 2022-06-10 |
| 2021-03-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-10 | $2.00K derived: sum of 2 quarters · filed 2022-06-10 | $3.00K derived: sum of 3 quarters · filed 2022-06-10 | $4.00K 10-K · filed 2022-06-10 |
| 2020-12-31 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-14 | $2.00K derived: sum of 2 quarters · filed 2022-02-14 | $3.00K 10-Q · filed 2022-02-14 | $3.00K derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-09-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08 | $2.00K 10-Q · filed 2021-11-08 | $2.00K derived: sum of 3 quarters · filed 2021-11-08 | $3.00K derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $1.00K 10-Q · filed 2021-08-06 | $1.00K derived: sum of 2 quarters · filed 2021-08-06 | $2.00K derived: sum of 3 quarters · filed 2021-08-06 | $10.00K derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | $1.00K derived: sum of 2 quarters · filed 2021-06-15 | $9.00K derived: sum of 3 quarters · filed 2021-06-15 | $61.00K 10-K · filed 2021-06-15 |
| 2019-12-31 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-08 | $9.00K derived: sum of 2 quarters · filed 2021-02-08 | $61.00K 10-Q · filed 2021-02-08 | $148.00K derived: sum of 4 quarters · filed 2021-02-08 |
| 2019-09-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-05 | $60.00K 10-Q · filed 2020-11-05 | $147.00K derived: sum of 3 quarters · filed 2020-11-05 | $138.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $52.00K 10-Q · filed 2020-08-10 | $139.00K derived: sum of 2 quarters · filed 2020-08-10 | $130.00K derived: sum of 3 quarters · filed 2020-08-10 | $172.00K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28 | $78.00K derived: sum of 2 quarters · filed 2020-05-28 | $120.00K derived: sum of 3 quarters · filed 2020-05-28 | $223.00K 10-K · filed 2020-05-28 |
| 2018-12-31 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $33.00K derived: sum of 2 quarters · filed 2020-02-10 | $136.00K 10-Q · filed 2020-02-10 | $156.00K derived: sum of 4 quarters · filed 2020-02-10 |
| 2018-09-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $145.00K 10-Q · filed 2019-11-07 | $165.00K derived: sum of 3 quarters · filed 2019-11-07 | $188.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $103.00K 10-Q · filed 2019-08-08 | $123.00K derived: sum of 2 quarters · filed 2019-08-08 | $146.00K derived: sum of 3 quarters · filed 2019-08-08 | $190.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-03 | $43.00K derived: sum of 2 quarters · filed 2019-06-03 | $87.00K derived: sum of 3 quarters · filed 2019-06-03 | $94.00K 10-K · filed 2019-06-03 |
| 2017-12-31 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-07 | $67.00K derived: sum of 2 quarters · filed 2019-02-07 | $74.00K 10-Q · filed 2019-02-07 | |
| 2017-09-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | $51.00K 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $7.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |